Brief: Advaxis Reports Second Quarter Financial Results And Provides A Business Update
14/06/2021 22:31
June 14 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS REPORTS SECOND QUARTER ENDED APRIL 30, 2021
FINANCIAL
RESULTS AND PROVIDES A BUSINESS UPDATE
* ADVAXIS INC - CASH RUNWAY ANTICIPATED INTO FISCAL 3RD
QUARTER OF
2023
* ADVAXIS INC - QTRLY LOSS PER SHARE $0.04
Source text for Eikon: ID:nGNXbYxlrm
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors